Dale Chappell
2020
In 2020, Dale Chappell earned a total compensation of $1.3M as Chief Scientific Officer at KaloBios Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $67,609 |
|---|---|
| Option Awards | $1,016,576 |
| Salary | $200,341 |
| Total | $1,284,526 |
Chappell received $1M in option awards, accounting for 79% of the total pay in 2020.
Chappell also received $67.6K in non-equity incentive plan and $200.3K in salary.
Rankings
In 2020, Dale Chappell's compensation ranked 7,536th out of 13,090 executives tracked by ExecPay. In other words, Chappell earned more than 42.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,536 out of 13,090 | 42nd |
Division Manufacturing | 3,172 out of 5,624 | 44th |
Major group Chemicals And Allied Products | 1,279 out of 2,257 | 43rd |
Industry group Drugs | 1,105 out of 1,957 | 44th |
Industry Pharmaceutical Preparations | 824 out of 1,462 | 44th |
Source: SEC filing on April 23, 2021.
Chappell's colleagues
We found three more compensation records of executives who worked with Dale Chappell at KaloBios Pharmaceuticals in 2020.